These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 27519706)
1. Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation. Patschan S; Tampe D; Müller C; Seitz C; Herink C; Müller GA; Zeisberg E; Zeisberg M; Henze E; Patschan D BMC Musculoskelet Disord; 2016 Aug; 17():339. PubMed ID: 27519706 [TBL] [Abstract][Full Text] [Related]
2. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis. Corallo C; Paulesu L; Cutolo M; Ietta F; Carotenuto C; Mannelli C; Romagnoli R; Nuti R; Giordano N Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S98-105. PubMed ID: 26005773 [TBL] [Abstract][Full Text] [Related]
3. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. Dooley A; Gao B; Bradley N; Abraham DJ; Black CM; Jacobs M; Bruckdorfer KR Rheumatology (Oxford); 2006 Jun; 45(6):676-84. PubMed ID: 16399843 [TBL] [Abstract][Full Text] [Related]
4. Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis. Manneschi LI; Del Rosso A; Milia AF; Tani A; Nosi D; Pignone A; Generini S; Giacomelli R; Cerinic MM Rheumatology (Oxford); 2005 May; 44(5):607-13. PubMed ID: 15728417 [TBL] [Abstract][Full Text] [Related]
5. Endothelial autophagy and Endothelial-to-Mesenchymal Transition (EndoMT) in eEPC treatment of ischemic AKI. Patschan D; Schwarze K; Henze E; Patschan S; Müller GA J Nephrol; 2016 Oct; 29(5):637-44. PubMed ID: 26289253 [TBL] [Abstract][Full Text] [Related]
6. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis. Tomita H; Ogawa F; Hara T; Yanaba K; Iwata Y; Muroi E; Yoshizaki A; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945 [TBL] [Abstract][Full Text] [Related]
7. Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study. Juhl P; Vinderslev Iversen L; Karlsmark T; Asser Karsdal M; Bay-Jensen AC; Mogensen M; Siebuhr AS Biomarkers; 2019 Jun; 24(4):373-378. PubMed ID: 30821519 [No Abstract] [Full Text] [Related]
8. Increased serum pentraxin 3 in patients with systemic sclerosis. Iwata Y; Yoshizaki A; Ogawa F; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S J Rheumatol; 2009 May; 36(5):976-83. PubMed ID: 19273457 [TBL] [Abstract][Full Text] [Related]
9. Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis. Patschan D; Sugiarto N; Henze E; Mößner R; Mohr J; Müller GA; Patschan S Eur J Med Res; 2018 Nov; 23(1):56. PubMed ID: 30413175 [TBL] [Abstract][Full Text] [Related]
10. Potential contribution of early endothelial progenitor cell (eEPC)-to-macrophage switching in the development of pulmonary plexogenic lesion. Shao FJ; Guo XL; Xu JX; Liu R; Li DY; Li QH; Zhou T; Fang C; Tan X Respir Res; 2022 Oct; 23(1):290. PubMed ID: 36274148 [TBL] [Abstract][Full Text] [Related]
11. Increased serum levels of fractalkine and mobilisation of CD34 Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472 [TBL] [Abstract][Full Text] [Related]
12. The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. Cipriani P; Di Benedetto P; Ruscitti P; Capece D; Zazzeroni F; Liakouli V; Pantano I; Berardicurti O; Carubbi F; Pecetti G; Turricchia S; Alesse E; Iglarz M; Giacomelli R J Rheumatol; 2015 Oct; 42(10):1808-16. PubMed ID: 26276964 [TBL] [Abstract][Full Text] [Related]
13. Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis. Miura S; Asano Y; Saigusa R; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Sato S; Kadono T J Dermatol; 2015 May; 42(5):461-6. PubMed ID: 25766303 [TBL] [Abstract][Full Text] [Related]
14. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320 [TBL] [Abstract][Full Text] [Related]
15. Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity. Franck-Larsson K; Hedenström H; Dahl R; Rönnblom A Scand J Rheumatol; 2003; 32(6):348-55. PubMed ID: 15080266 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies. Altorok N; Tsou PS; Coit P; Khanna D; Sawalha AH Ann Rheum Dis; 2015 Aug; 74(8):1612-20. PubMed ID: 24812288 [TBL] [Abstract][Full Text] [Related]